Annual Total Expenses
$341.98 M
+$118.41 M+52.96%
December 31, 2023
Summary
- As of February 12, 2025, AMLX annual total expenses is $341.98 million, with the most recent change of +$118.41 million (+52.96%) on December 31, 2023.
- During the last 3 years, AMLX annual total expenses has risen by +$302.98 million (+776.77%).
- AMLX annual total expenses is now at all-time high.
Performance
AMLX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$39.87 M
-$12.54 M-23.92%
September 30, 2024
Summary
- As of February 12, 2025, AMLX quarterly total expenses is $39.87 million, with the most recent change of -$12.54 million (-23.92%) on September 30, 2024.
- Over the past year, AMLX quarterly total expenses has dropped by -$44.10 million (-52.52%).
- AMLX quarterly total expenses is now -81.08% below its all-time high of $210.77 million, reached on March 31, 2024.
Performance
AMLX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
AMLX Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +53.0% | -52.5% |
3 y3 years | +776.8% | -52.5% |
5 y5 years | +2423.1% | -52.5% |
AMLX Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +313.6% | -81.1% | +40.8% |
5 y | 5-year | at high | +2423.1% | -81.1% | +364.1% |
alltime | all time | at high | +2423.1% | -81.1% | +364.1% |
Amylyx Pharmaceuticals Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $39.87 M(-23.9%) |
Jun 2024 | - | $52.41 M(-75.1%) |
Mar 2024 | - | $210.77 M(+97.9%) |
Dec 2023 | $341.98 M(+53.0%) | $106.52 M(+26.8%) |
Sep 2023 | - | $83.97 M(+7.6%) |
Jun 2023 | - | $78.02 M(+6.2%) |
Mar 2023 | - | $73.48 M(+10.5%) |
Dec 2022 | $223.57 M | $66.48 M(+20.8%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $55.03 M(+1.4%) |
Jun 2022 | - | $54.25 M(+13.5%) |
Mar 2022 | - | $47.81 M(+68.9%) |
Dec 2021 | $82.69 M(+112.0%) | $28.32 M(+23.5%) |
Sep 2021 | - | $22.92 M(+23.3%) |
Jun 2021 | - | $18.59 M(+44.4%) |
Mar 2021 | - | $12.87 M(+49.8%) |
Dec 2020 | $39.01 M(+187.8%) | $8.59 M |
Dec 2019 | $13.55 M | - |
FAQ
- What is Amylyx Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual total expenses year-on-year change?
- What is Amylyx Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly total expenses year-on-year change?
What is Amylyx Pharmaceuticals annual total expenses?
The current annual total expenses of AMLX is $341.98 M
What is the all time high annual total expenses for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual total expenses is $341.98 M
What is Amylyx Pharmaceuticals annual total expenses year-on-year change?
Over the past year, AMLX annual total expenses has changed by +$118.41 M (+52.96%)
What is Amylyx Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of AMLX is $39.87 M
What is the all time high quarterly total expenses for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly total expenses is $210.77 M
What is Amylyx Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, AMLX quarterly total expenses has changed by -$44.10 M (-52.52%)